Gang Zeng

Company: T-Cure Biosciences Inc.

Job title: CEO

Seminars:

Leveraging the Insights Gained from TIL Therapy to Improve 15-T 3:00 pm

Exploring the success of TIL therapy in the context of solid tumors and how it has addressed the issue of tumor heterogeneity How to leverage TCR therapies across a population in terms of diversity? How to address tumor heterogeneity with regards to solid tumor efficacy?Read more

day: Day One

Industry Leaders Fireside Chat – What Does the Future Hold for TCR therapies? 10:30 am

The hotly anticipated Industry Leader’s Fireside Chat will discuss the huge progress being made in the TCR therapeutic space. This session will explore the lessons we can takes from CAR-T, and will shed clarity on the priorities of the trailblazing companies in this field, whilst also touching upon the challenges faced with manufacturing costs, and…Read more

day: Day One